Skip to content
Screener

Immunovant, Inc. IMVT Acquired in-process research and development

Acquired in-process research and development at other companies

Corvex logo
CorvexMOVE
$822K-65.2%
Accenture logo
AccentureACN
$204.33M-29.0%
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$6.97M+133%
Immunome logo
ImmunomeIMNM
$9.01M+44.3%
DJT
Trump Media & Technology GroupDJT
$8.4M-33.1%
Anterix logo
AnterixATEX
$53.5M+30.7%

Segments

By segment

See full
Reportable Segment$0—

Other financials

Income statement

See full
Net income-$147.9M-38.9%
EPS (diluted)-$0.73-15.9%

Balance sheet

See full
Cash & equivalents$902.1M+26.4%
Total debt$72.0K-26.5%
Total equity$852.6M+20.5%
Total assets$957.0M+23.3%

Cash flow

See full
Operating cash flow-$95.1M+14.1%
CapEx$8.0K-96.0%
Free cash flow-$95.1M+14.2%

Valuation

See full
Market cap$8.21B+201%
Enterprise value$7.31B+89.7%

Returns & leverage

See full
Return on equity-64.8%+2.5pp
Debt / equity0×0.0×
Current ratio9.1×-2.1×